These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17505590)

  • 21. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Mitsi G; Chroni E
    Eur J Neurol; 2007 Nov; 14(11):e6. PubMed ID: 17956439
    [No Abstract]   [Full Text] [Related]  

  • 24. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
    Gosal D; Lynch T; Ross OA; Haugarvoll K; Farrer MJ; Gibson JM
    Mov Disord; 2007 Jan; 22(2):291-2. PubMed ID: 17089395
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
    Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
    Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.
    Cookson MR
    Nat Rev Neurosci; 2010 Dec; 11(12):791-7. PubMed ID: 21088684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.
    Bonifati V
    Eur J Hum Genet; 2006 Oct; 14(10):1061-2. PubMed ID: 16835587
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
    Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC;
    Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.
    Lu CS; Simons EJ; Wu-Chou YH; Fonzo AD; Chang HC; Chen RS; Weng YH; Rohé CF; Breedveld GJ; Hattori N; Gasser T; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2005 Dec; 11(8):521-2. PubMed ID: 16256409
    [No Abstract]   [Full Text] [Related]  

  • 31. Lrrk2 in the limelight!
    Farrer MJ
    Neurology; 2007 Oct; 69(18):1732-3. PubMed ID: 17967990
    [No Abstract]   [Full Text] [Related]  

  • 32. LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP.
    Spanaki C; Latsoudis H; Plaitakis A
    Neurology; 2006 Oct; 67(8):1518-9. PubMed ID: 17060595
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation.
    Deng H; Le W; Guo Y; Hunter CB; Xie W; Jankovic J
    Ann Neurol; 2005 Jun; 57(6):933-4. PubMed ID: 15929036
    [No Abstract]   [Full Text] [Related]  

  • 34. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.
    Funayama M; Hasegawa K; Ohta E; Kawashima N; Komiyama M; Kowa H; Tsuji S; Obata F
    Ann Neurol; 2005 Jun; 57(6):918-21. PubMed ID: 15880653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families.
    Ohta E; Hasegawa K; Gasser T; Obata F
    Neurosci Lett; 2007 Apr; 417(1):21-3. PubMed ID: 17395370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of Parkinson's disease: LRRK2 on the rise.
    Brice A
    Brain; 2005 Dec; 128(Pt 12):2760-2. PubMed ID: 16311269
    [No Abstract]   [Full Text] [Related]  

  • 39. LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.
    Esteves AR; Swerdlow RH; Cardoso SM
    Exp Neurol; 2014 Nov; 261():206-16. PubMed ID: 24907399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients.
    Nuytemans K; Rademakers R; Theuns J; Pals P; Engelborghs S; Pickut B; de Pooter T; Peeters K; Mattheijssens M; Van den Broeck M; Cras P; De Deyn PP; van Broeckhoven C
    Eur J Hum Genet; 2008 Apr; 16(4):471-9. PubMed ID: 18197194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.